Faller Douglas Vincent, CMO, reported a transaction classified as grant at Imunon, Inc. involving 100000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 100000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
Form 4 relationship flags and nearby filing context
Chief Medical Officer
Represents the closing price of Imunon, Inc. Common Stock on the date of the grant
The options shall vest and become exercisable as to 1/4 on the one year anniversary of the grant date and each remaining 1/4 on the second, third and fourth year anniversary of the grant date, subject…
0 other filings
0 recent txs